CN103041404A - Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine - Google Patents

Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine Download PDF

Info

Publication number
CN103041404A
CN103041404A CN2012101537081A CN201210153708A CN103041404A CN 103041404 A CN103041404 A CN 103041404A CN 2012101537081 A CN2012101537081 A CN 2012101537081A CN 201210153708 A CN201210153708 A CN 201210153708A CN 103041404 A CN103041404 A CN 103041404A
Authority
CN
China
Prior art keywords
dna
preparation
gene
promoter
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101537081A
Other languages
Chinese (zh)
Inventor
李琦
滕以刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI QIHAIFUTAI BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
SHANGHAI QIHAIFUTAI BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI QIHAIFUTAI BIOLOGICAL TECHNOLOGY Co Ltd filed Critical SHANGHAI QIHAIFUTAI BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN2012101537081A priority Critical patent/CN103041404A/en
Publication of CN103041404A publication Critical patent/CN103041404A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention provides a fish iridovirus DNA (Deoxyribonucleic Acid) vaccine which comprises an eukaryotic transcription promoter, a gene of an iridovirus major capsid protein (MCP), an ankyrinrepeats gene, an eukaryotic transcription terminator, a replication initiation site and a resistance screening marker (shown in figure 1), wherein the replication initiation site and the resistance screening marker are used for amplifying plasmids. The DNA vaccine is recommended to be injected by an intramuscular injection method and can also be taken by oral and soaking modes to enable fish to be immune.

Description

A kind of fish iridovirus dna vaccination preparation method
Technical field
The invention belongs to biomedicine field, particularly dna vaccination preparation method in a kind of aquaculture, the dna vaccination preparation method of preventing and treating specifically irido virus.
Background technology
The present invention relates to coding and express the immunogenic vector construction of fish irido virus, irido virus is a kind of Causative virus of causing massive losses in the fish production, and fatality rate is up to more than 60%.This patent relates to the method for this vaccine of production and preparation, has also related to the inoculation method of irido virus dna vaccination.
Irido virus main infection invertebrates waits vertebrates with hanging down, large-scale 20 body shape DNA viruses, be divided into iridescent virus (Iridovirus), Chloriridovirus belongs to (Chloriridovirus), Lymphocystivirus (Lymphocystivirus), Ranavirus (Ranavirus) and Megalocytivirus belong to (Megalocytivirus).The irido virus that brings about great losses in aquatic products industry has Red snapper irido virus (red sea bream iridovirus), Taiwan grouper irido virus (Taiwan Grouper iridovirus), infectious spleen and kidney necrosis virus (Infectious spleen and kidney necrosis virus), Carnis Pseudosciaenae irido virus (Large yellow croaker iridovirus) and turbot reddish body iridovirus (Turbot reddish body iridovirus).
The virus type disease does not have effective medicine to control, and the vaccination prevention is a kind of cost-effective means for the virus type disease.The irido virus vaccine of using in the world at present only has Japanese madai irido virus vaccine (Kazuhiro Nakajima etc, Effectiveness of a vaccine against red sea bream iridovirus disease in a field trial test, Dis Aquat Org, Vol. 36:73-75,1999), its vaccine adopts the ablation method preparation.Irido virus vaccine in the domestic research and development is also all taked the ablation method preparation, and the cultivation of virus makes the production cost of vaccine very expensive, and this has limited the popularization of vaccine.
Main capsid protein is the important immunogen of irido virus, ankyrin repeat containing protein also has bibliographical information, and it has immunogenicity (Yun Im Kim etc, Production of polyclonal antibody against recombinant ORF 112L of rock bream iridovirus and in vitro neutralization).
The present invention is a kind of dna vaccination; pass through immunity inoculation; make fish oneself expression irido virus major capsid protein and this two-strain albumen of ankyrin repeats containing protein; pass through angtigen presentation; make the immunocyte generation of fish for the antibody of these two kinds of protein, thereby reach the effect of immunoprotection.
Summary of the invention
The objective of the invention is to make up a dna vaccination, by inoculation, Fish self can be expressed the immunogenic protein of having of irido virus, and then produce the antibody to irido virus, and the protection Fish avoid the infringement of irido virus.
Dna vaccination provided by the invention comprises following content:
A) plasmid construction:
The amicillin resistance screening is compared and the protokaryon replication origin is taken from plasmid pBR322, NdeI and EcoRI enzyme action, and Agrose glue reclaims the fragment of 2Kb; MCP gene and ankyrin repeats containing protein gene are that full gene is synthetic, and its front adds eukaryotic promoter, and the back adds terminator.Gene splicing becomes a bar segment, is connected with the amp fragment with the ori of plasmid pBR322 by homologous recombination, transforms escherichia coli DH5a (Fig. 1).Select positive colony, the dna sequencing checking;
B) after the above plasmid that makes up and normal saline, adjuvant mix, obtain dna vaccination.
Description of drawings
Below in conjunction with description of drawings feature of the present invention and beneficial effect.
Fig. 1 is the expression vector schematic diagram.
This dna vaccination is compared with the vaccine that the other technologies route makes up has following advantage:
A, production cost are low, are fit to produce in enormous quantities; Dna molecular is stable, is fit to storage and transportation;
B, safety, what dna vaccination was expressed is one section viral gene, viral inversion can not occur;
C, this dna vaccination are expressed MCP and ankyrin repeats protein simultaneously, and it is two valency vaccines, and simultaneously dna molecular itself just can be used as adjuvant, can with normal saline mixing direct injection.
The specific embodiment
The preparation of embodiment 1:DNA vaccine
Vector construction:
The synthetic fragment Pcmv-MCP-SV40 pA-Pcmv-ankyrin repeats-SV40 pA of full gene, MCP and ankyrin repeats nucleotide sequence see appendix.This fragment is with the 2k fragment homologous recombination (GBI) on the plasmid pBR322, and reaction system is: 15ul GBclonart reactant liquor; 1ul pBR322 fragment; The full gene of 2ul synthesizes fragment; 2ul ddH2O.50 ℃ hatch 30min after, get 5ul and transform escherichia coli DH5a.The screening of ampicillin LB solid plate.Sequence verification is correctly cloned, 500ml LB culture medium amplification culture, and a large amount of extracting plasmids are for subsequent use.The prescription of liquid LB culture medium is: 0.5% yeast extract; 1% peptone; 1% sodium chloride, bar pH value to 7.0,121 ℃, sterilization in 15 minutes.Solid LB culture medium is to add 1.5% agar powder on the basis of liquid LB culture medium;
The dna vaccination prescription:
The normal saline prescription is that 0.65% sodium chloride is dissolved in distilled water, and the concentration of sodium chloride can make between 0.5% to 0.9%.Also can be Ren Shi normal saline or Le Shi normal saline.Recommend the dna vaccination prescription to be: 1ugDNA is dissolved in the 1ul normal saline.
Embodiment 2: the drug administration by injection immunoprotection experiment take turbot as object
The test turbot is divided into 14 groups, every group of 3 tanks, 10 tails/groove at random.The dna vaccination of preparation is adopted the muscle injection mode immunity, and injection volume is 1ug/ tail and 10ug/ tail, contrasts to be normal saline.After 4 weeks of immunity, with irido virus counteracting toxic substances (105CFU/ tail).Observe death toll after 15 days, calculate every group immune protective rate (seeing Table 1).
Table 1
Figure 614829DEST_PATH_IMAGE002
As can be seen from above, this dna vaccination has good prevention effect to irido virus, and immune protective rate is 82%.
1. MCP nucleotide sequence:
atgtctgcaatctcaggtgcgaacgtaaccagtgggttcatcgacatctccgctttcgatgcgatggagacccacttgtacggcggcgacaatgccgtgacatactttgcccgcgagaccgtgcgtagttcctggtacagcaaactacccgtcaccctgtcaaaacagactggccatgccaatttcggccaggagtttagtgtgacggtggccaggggtggcgactacctcattaatgtgtggctgcgtgttaagatcccctccatcacatccagcaaggaaaacagctacattcgctggtgtgacaatctgatgcacaatctggttgaggaggtgtcggtgtcatttaacgacctggtggcacagaccctgaccagcgagttcctcgacttttggaacgcctgcatgatgcccggcagcaaacagtctggctataacaagatgattggcatgcgcagcgacctggtctccggtatcaccaacggtcacactatgcctgctacctacctcaatttgcccatccccctcttcttcacccgcgacacaggccttgcattgcccaccgtgtctctgccgtacaacgaggtgcgcatccacttcaagctgcggcgctgggaggacctgctcatcagccagagcacccaggccgacatggccatctcgaccgtcaccctggccaacattagcaatgtagcacccgcgttgaccaacgtttccgtgatgggcacctacgctgtgctgacaagtgaggagcgcgaggtggtggcccagtctagccgtagcatgctcattgaacagtgccaggtggcgcctcgtgtgcccgtcacacccgcagacaattccttggtgcatctggacctcaggttcagtcatcccgtcaaggccttgttctttgcagtaaagaacgtcacccaccgcaacgtgcaaagcaattacaccgcggccagtcccgtgtatgtcaacaacaaggtcaatctgcctttgctggccaccaatcccctgtccgaggtgtcactcatttacgagaacacccctcggctccaccagatgggagtggactacttcacatccgtcgacccctactactttgcgcccagcatgcctgagatggacggtgttatgacctactgctataccctggacatgggcaatatcaaccccatgggctcgaccaactacggccgcctgtccaacgtcaccctgtcatgtaaggtgtcggacaacgccaagaaaacagcagcgggcggcggaaccaacggcagcggctacacggtcgcccaaaagtttgaactggtcgttattgcagtcaaccacaacatcatgaagattgctgacggcgctgcaggcttccctatcctgtaa
?
2. ankyrin repeats sequence:
atgtatgttctcaagtaccatgaagctgggatgtgtgttatgctccttggccagctgcgccacaaagtcgtcataggtctgcatggcgtgcagttgcgcctcatgccgtgctccattccacaccgtgtgaatggccaacatgtttttttggtaataaaaatggattcccttgtcgacctcatccgggctggcggtgtgcctgatgtggctcaatatgccgatcaggtggatgaatacaatgcggagggcttcacgccgctgatggtggccgtggaagccggcaacgcgggcgccgtacgcgcgctgctcaccatgggtgcggaccccaacgatggccatgcgcatggccaccgcgtgcctcttattgcggcagtaggcgggccatgggatgtgtttgtggctctgttgcagagtccgcggctacgagtcaatgcgcgcaacagtagccacgagaccgctctgcactacgccgcagacgcgggtgacgctcaggccacagaggcgctgttgcgtgccggtgccgacgtgaacgcaatagacatacttggcaacagtccactgtttggggccatcgcaaacgtacaggtggcgtccgtactaatgcacgccggcgccgacgtcaacatcgtcaacaacgcagatcacacgttcgtacagaatgtctttgaacacgtggccacggcgcatgacaaagacgccgtggcagtgccaatggccctagaggcggtgagacacgggctacgcatgacagccacggagctacagcgcatccttgatgtcgagcaccttggcacacctttcgcagtgactatcgtgtcagcgcttgacaacgttgacatgggcatgtgtcatgaaacaggacacgacgctgtacagtacacggtggccataggcctgaccaccgtgacagactttctggtggccttgctggactacgatgtcgacagcctggttcaaatggccgtctcgggccccaacccggctgtcatgatcatgttgattgagaaatacgagatggatgtgcaccagaggcccggcgcgcagcttctgctcaacgccttggtcaacaacaacgtggcttcggcgcgctaccttgcactggaggcaggcgttaccgtggacccctgtgatgtgtccgccctgatcaccgccttaatggtctcacagaactttcagcttgtcaaggacatgtctcgccactacaatttagacatggtgacgccgatagacggccgctcgccgctggacttgctggtatccaccgtggcccaagtcgacgaggactttatagtggactttatcacatatttcacgccgcgacagggggtatcactgttgacgggccaggtcccaccgtacatgtacgtgggccgcgtggggctggcttacactcacatgatgaccctgaggaacatggccatcggggcgctgccgtggcacagccgggattccgcgcagacacacattgactttggggtatataaaacactatga

Claims (6)

1. irido virus dna vaccination preparation method is characterized in that this dna vector:
A) contain the gene of encoding and expressing irido virus capsid protein (MCP);
B) contain coding ankyrin repeats gene;
C) can be the mixture that contains simultaneously capsid protein and two genes of ankyrin repeats.
2. such as right 1 described dna vector, the promoter of the immunogenic gene on the carrier and enhancer can be the strong promoter commonly used such as Pcmv etc., also can be to make eukaryotic cell especially composing type or the tissue-specific promoter in Fish source, such as ATP enzyme promoter, actin promoter etc.
3. the application in the control of preparation cultured fishes irido virus such as right 1 and 2 described dna vaccinations.
4. such as right 3 described application, it is characterized in that, wherein said preparation is: such as right 1 and 2 described dna vectors, normal saline and immunological adjuvant.
5. such as right 3 described application, it is characterized in that, wherein prepared dna vaccination is by the injection system administration, and administration concentration is the 1-10ug/ tail.
6. such as right 3 described application, it is characterized in that, wherein prepared dna vaccination is by soaking administration, and administration concentration is the 1-10ug/ tail.
CN2012101537081A 2012-05-17 2012-05-17 Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine Pending CN103041404A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101537081A CN103041404A (en) 2012-05-17 2012-05-17 Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101537081A CN103041404A (en) 2012-05-17 2012-05-17 Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine

Publications (1)

Publication Number Publication Date
CN103041404A true CN103041404A (en) 2013-04-17

Family

ID=48054411

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101537081A Pending CN103041404A (en) 2012-05-17 2012-05-17 Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine

Country Status (1)

Country Link
CN (1) CN103041404A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104096240A (en) * 2014-06-20 2014-10-15 中国水产科学研究院珠江水产研究所 DNA vaccine with resistance to infectious spleen and kidney necrosis viruses
TWI558725B (en) * 2014-07-18 2016-11-21 國立臺灣海洋大學 Orally multivalent vaccine composition
CN106310295A (en) * 2016-10-26 2017-01-11 武汉市农业科学技术研究院水产科学研究所 Method for preventing mandarin fish ISKNV through DNA vaccine immersion immunization
CN110279854A (en) * 2019-07-19 2019-09-27 暨南大学 A kind of Micropterus salmoides virus DNA vaccine and the preparation method and application thereof
CN116949067A (en) * 2023-09-20 2023-10-27 深圳万可森生物科技有限公司 Nerve necrosis virus CP4 protein coding gene, preparation method and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101168063A (en) * 2007-11-07 2008-04-30 中山大学 Spring viremia of carp virus DNA vaccine and preparation method thereof
CN102277361A (en) * 2011-04-29 2011-12-14 中国科学院南海海洋研究所 Method for screening protective antigens of Singapore grouper iridovirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101168063A (en) * 2007-11-07 2008-04-30 中山大学 Spring viremia of carp virus DNA vaccine and preparation method thereof
CN102277361A (en) * 2011-04-29 2011-12-14 中国科学院南海海洋研究所 Method for screening protective antigens of Singapore grouper iridovirus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHANG-JUN GUO等: "The viral ankyrin repeat protein (ORF124L) from infectious spleen and kidney necrosis virus attenuates nuclear factor-kB activation and interacts with IkB kinase b", 《JOURNAL OF GENERAL VIROLOGY》, vol. 92, 31 July 2011 (2011-07-31), pages 1561 - 1570 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104096240A (en) * 2014-06-20 2014-10-15 中国水产科学研究院珠江水产研究所 DNA vaccine with resistance to infectious spleen and kidney necrosis viruses
TWI558725B (en) * 2014-07-18 2016-11-21 國立臺灣海洋大學 Orally multivalent vaccine composition
CN106310295A (en) * 2016-10-26 2017-01-11 武汉市农业科学技术研究院水产科学研究所 Method for preventing mandarin fish ISKNV through DNA vaccine immersion immunization
CN110279854A (en) * 2019-07-19 2019-09-27 暨南大学 A kind of Micropterus salmoides virus DNA vaccine and the preparation method and application thereof
CN116949067A (en) * 2023-09-20 2023-10-27 深圳万可森生物科技有限公司 Nerve necrosis virus CP4 protein coding gene, preparation method and application
CN116949067B (en) * 2023-09-20 2023-11-21 深圳万可森生物科技有限公司 Nerve necrosis virus CP4 protein coding gene, preparation method and application

Similar Documents

Publication Publication Date Title
Guo et al. Carbon nanotubes-loaded subunit vaccine can increase protective immunity against rhabdovirus infections of largemouth bass (Micropterus Salmoides)
CN103041404A (en) Preparation method of fish iridovirus DNA (Deoxyribonucleic Acid) vaccine
Zhang et al. Single-walled carbon nanotubes as delivery vehicles enhance the immunoprotective effect of a DNA vaccine against spring viremia of carp virus in common carp
Le Linh et al. Yeast cell surface displaying VP28 antigen and its potential application for shrimp farming
CN100566752C (en) Fishes infectious spleen and kidney necrosis virus gene engineering vaccine and preparation method thereof
Zheng et al. Immersion immunization of common carp with bacterial ghost‐based DNA vaccine inducing prophylactic protective immunity against spring viraemia of carp virus
CN104530230B (en) A kind of duck hepatitis A virus VP1 GFPs and its application
CN103830746A (en) Riemerella anatipestifer deoxyribonucleic acid (DNA) vaccine based on OmpA (octamethyl pyrophosphoramide) gene and preparation method of vaccine
CN103352047B (en) Trichinella Spiralis larva ES antigen gene vaccine and preparation method
CN102206257B (en) Edwardsiella tarda immunogenic protective antigen, and related expression vector, vaccine and application
CN104404057A (en) Giant salamander iridescent virus vaccine, preparation method and application
CN104448005B (en) The fusion rotein antigen of duck hepatitis A virus (HAV) 3 type VP1 albumen and LTB and application thereof
CN101879317A (en) Preparation method and application of Vibro harveyi and Vibrio parahaemolyticus bigeminy DNA vaccine
CN102603898B (en) Fowl adenovirus group I immunity related fusion protein as well as encoding gene and application thereof
CN110101854B (en) Carp herpesvirus III type vaccine and preparation method thereof
JP6709395B2 (en) Cold water vaccine and method for preventing cold water disease
CN103495159B (en) The preparation method of flavobacterium columnare genetic vaccine
CN103316358A (en) Bivalent DNA (Deoxyribonucleic Acid) vaccine and preparation method thereof
CN102973930B (en) Chicken subunit bivalent vaccine, as well as preparation and application thereof
CN101659958A (en) Multi-titer live vaccine as well as preparation method and application thereof
CN101947325A (en) Vibrio paraheamolyticus bivalent DNA vaccine as well as preparation method and application thereof
CN105566461B (en) Bacterial outer membrane proteins ompAs-19 after DNA reorganization and its application as immunomodulator
CN103589693A (en) Recombinant HVT (herpesvirus of turkey) expressing IBDV (infectious bursal disease virus) VP2 and bursin chimeric protein
CN106995489B (en) A kind of Streptococcus suis truncated protein Sao and application
CN103990146A (en) Immunopotentiator for ducks and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130417